JP2016536372A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016536372A5 JP2016536372A5 JP2016553225A JP2016553225A JP2016536372A5 JP 2016536372 A5 JP2016536372 A5 JP 2016536372A5 JP 2016553225 A JP2016553225 A JP 2016553225A JP 2016553225 A JP2016553225 A JP 2016553225A JP 2016536372 A5 JP2016536372 A5 JP 2016536372A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- residue
- hydrogen
- alkyl
- heterocyclyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 31
- 229910052739 hydrogen Inorganic materials 0.000 claims 30
- 239000001257 hydrogen Substances 0.000 claims 30
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 28
- 125000000623 heterocyclic group Chemical group 0.000 claims 25
- 125000004452 carbocyclyl group Chemical group 0.000 claims 20
- 125000004404 heteroalkyl group Chemical group 0.000 claims 20
- 125000001072 heteroaryl group Chemical group 0.000 claims 20
- 125000000217 alkyl group Chemical group 0.000 claims 15
- 108010016626 Dipeptides Proteins 0.000 claims 13
- 125000003342 alkenyl group Chemical group 0.000 claims 11
- 125000000539 amino acid group Chemical group 0.000 claims 11
- 125000000304 alkynyl group Chemical group 0.000 claims 10
- 125000003118 aryl group Chemical group 0.000 claims 10
- 125000005017 substituted alkenyl group Chemical group 0.000 claims 10
- 125000000547 substituted alkyl group Chemical group 0.000 claims 10
- 125000004426 substituted alkynyl group Chemical group 0.000 claims 10
- 125000003107 substituted aryl group Chemical group 0.000 claims 10
- 125000002947 alkylene group Chemical group 0.000 claims 8
- 125000000732 arylene group Chemical group 0.000 claims 8
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 claims 6
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 4
- 150000003904 phospholipids Chemical group 0.000 claims 4
- 125000005457 triglyceride group Chemical group 0.000 claims 4
- 108010078791 Carrier Proteins Proteins 0.000 claims 3
- 125000004429 atom Chemical group 0.000 claims 3
- 229960003624 creatine Drugs 0.000 claims 3
- 239000006046 creatine Substances 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 239000012453 solvate Substances 0.000 claims 3
- 229940124597 therapeutic agent Drugs 0.000 claims 3
- 208000021075 Creatine deficiency syndrome Diseases 0.000 claims 2
- 235000010323 ascorbic acid Nutrition 0.000 claims 2
- 239000011668 ascorbic acid Substances 0.000 claims 2
- 201000008609 cerebral creatine deficiency syndrome Diseases 0.000 claims 2
- 230000007812 deficiency Effects 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 150000002431 hydrogen Chemical class 0.000 claims 2
- 230000001404 mediated effect Effects 0.000 claims 2
- 108050005273 Amino acid transporters Proteins 0.000 claims 1
- 102000034263 Amino acid transporters Human genes 0.000 claims 1
- 108091052347 Glucose transporter family Proteins 0.000 claims 1
- 102000042092 Glucose transporter family Human genes 0.000 claims 1
- OBSIQMZKFXFYLV-QMMMGPOBSA-N L-phenylalanine amide Chemical compound NC(=O)[C@@H](N)CC1=CC=CC=C1 OBSIQMZKFXFYLV-QMMMGPOBSA-N 0.000 claims 1
- 102000000562 Monocarboxylic Acid Transporters Human genes 0.000 claims 1
- 101710204259 Monocarboxylic acid transporter Proteins 0.000 claims 1
- 102100023153 Sodium- and chloride-dependent creatine transporter 1 Human genes 0.000 claims 1
- 229940072107 ascorbate Drugs 0.000 claims 1
- 229960005070 ascorbic acid Drugs 0.000 claims 1
- 125000001369 canonical nucleoside group Chemical group 0.000 claims 1
- 108010007169 creatine transporter Proteins 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000004064 dysfunction Effects 0.000 claims 1
- 108010062890 glutathione transporter Proteins 0.000 claims 1
- 108091006527 nucleoside transporters Proteins 0.000 claims 1
- 102000037831 nucleoside transporters Human genes 0.000 claims 1
- 108010082406 peptide permease Proteins 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361899975P | 2013-11-05 | 2013-11-05 | |
| US61/899,975 | 2013-11-05 | ||
| PCT/US2014/064028 WO2015069699A1 (en) | 2013-11-05 | 2014-11-05 | Creatine analogs and the use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016536372A JP2016536372A (ja) | 2016-11-24 |
| JP2016536372A5 true JP2016536372A5 (OSRAM) | 2017-10-19 |
Family
ID=53042015
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016553225A Pending JP2016536372A (ja) | 2013-11-05 | 2014-11-05 | クレアチン類似体及びその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20160289175A1 (OSRAM) |
| EP (1) | EP3065726A4 (OSRAM) |
| JP (1) | JP2016536372A (OSRAM) |
| AU (1) | AU2014346952A1 (OSRAM) |
| CA (1) | CA2929538A1 (OSRAM) |
| WO (1) | WO2015069699A1 (OSRAM) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9617230B2 (en) | 2014-12-22 | 2017-04-11 | Farmington Pharma Development | Creatine prodrugs, compositions and methods of use thereof |
| WO2016110822A1 (en) * | 2015-01-09 | 2016-07-14 | Universita' Degli Studi Di Genova | Carboxylic biacyl creatine derivative, uses and method of synthesis thereof |
| AR104144A1 (es) | 2015-03-30 | 2017-06-28 | Farmington Pharma Dev | Profármacos de análogos de fosfato de creatina, sus composiciones y sus usos |
| MX2020005707A (es) | 2017-12-01 | 2020-08-20 | Ultragenyx Pharmaceutical Inc | Profarmacos de creatina, composiciones y metodos de uso de estos. |
| JP2023523033A (ja) | 2020-04-23 | 2023-06-01 | カロサイト・インコーポレイテッド | 自己組織化する酸素キャリアー組成物 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001290939B2 (en) * | 2000-09-14 | 2005-06-16 | Board Of Regents Of The University Of Nebraska | Creatine ester pronutrient compounds and formulations |
| US7125568B2 (en) * | 2001-08-23 | 2006-10-24 | Sung Michael T | Lipophilic drug compositions |
| EP1567180A4 (en) * | 2002-06-04 | 2010-03-10 | Avicena Group Inc | METHODS OF TREATING COGNITIVE DYSFUNCTIONS BY MODULATING BRAIN ENERGY METABOLISM |
| US20080103202A1 (en) * | 2004-11-08 | 2008-05-01 | Chris Ferguson | Method of preparing creatine ester salts and uses thereof. |
| US20070281996A1 (en) * | 2006-06-06 | 2007-12-06 | Xenoport, Inc. | Creatine prodrugs, compositions and uses thereof |
| AU2007332800A1 (en) * | 2006-12-07 | 2008-06-19 | Avicena Group, Inc. | Creatine compositions for skin treatment |
| WO2008101310A1 (en) * | 2007-02-20 | 2008-08-28 | Multi Formulations Ltd. | Creatine-fatty acids |
| US7314945B1 (en) * | 2007-02-20 | 2008-01-01 | Multi Formulations Ltd. | Creatine-fatty acids |
| US8546369B2 (en) * | 2008-05-30 | 2013-10-01 | Northern Innovations Holding Corp. | Salts of creatine imino sugar amides |
| EP2269980A4 (de) * | 2008-12-24 | 2011-05-18 | Vertex Closed Joint Stock Company | Creatinamide, verfahren zu ihrer herstellung und wirkstoff zur ausführung einer neuroprotektiven aktion |
| US20100215707A1 (en) * | 2009-02-25 | 2010-08-26 | Mcdonald Thomas | Activated creatinine and precursors thereof as antibacterial agents, compositions and products containing such agents and uses thereof |
| RU2428414C2 (ru) * | 2009-11-03 | 2011-09-10 | Закрытое Акционерное Общество "Вертекс" | Способ получения амидов креатина |
| US8445466B2 (en) * | 2010-04-08 | 2013-05-21 | John H. Owoc | Stable aqueous compositions comprising amide-protected bioactive creatine species and uses thereof |
| AU2012312654B2 (en) * | 2011-09-19 | 2017-04-13 | Gencia Corporation | Modified creatine compounds |
| DK2692719T3 (en) * | 2012-07-30 | 2016-09-12 | Commissariat L Energie Atomique Et Aux Energies Alternatives | A process for the preparation of kreatinfedtestere, thus prepared and to their use kreatinfedtestere |
-
2014
- 2014-11-05 WO PCT/US2014/064028 patent/WO2015069699A1/en not_active Ceased
- 2014-11-05 US US15/034,658 patent/US20160289175A1/en not_active Abandoned
- 2014-11-05 EP EP14859445.0A patent/EP3065726A4/en not_active Withdrawn
- 2014-11-05 JP JP2016553225A patent/JP2016536372A/ja active Pending
- 2014-11-05 CA CA2929538A patent/CA2929538A1/en not_active Abandoned
- 2014-11-05 AU AU2014346952A patent/AU2014346952A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102666477B1 (ko) | 글루타민 유사체의 프로드럭 | |
| JP2016536372A5 (OSRAM) | ||
| JP2018016629A5 (OSRAM) | ||
| JP2016153410A5 (OSRAM) | ||
| AU2010208071C1 (en) | Cyclosporin analogues for preventing or treating hepatitis C infection | |
| JP2008509166A5 (OSRAM) | ||
| JP2010508362A5 (OSRAM) | ||
| US8481483B2 (en) | Cyclosporin analogues | |
| JP2010508361A5 (OSRAM) | ||
| JP2019514426A5 (OSRAM) | ||
| JP2008522981A5 (OSRAM) | ||
| JP2013537907A5 (OSRAM) | ||
| CN105813640A (zh) | 作为免疫调节剂的环肽类化合物 | |
| JP2012512898A5 (OSRAM) | ||
| JP2018528261A5 (OSRAM) | ||
| JP2009538348A5 (OSRAM) | ||
| JP2013537195A5 (ja) | 疾患を治療するための医薬品及び同医薬品を含むキット | |
| CN105814028A (zh) | 作为免疫调节剂的1，2，4-*二唑衍生物 | |
| JP2013511554A5 (OSRAM) | ||
| JP2015024998A5 (OSRAM) | ||
| JP2010514768A5 (OSRAM) | ||
| JP2013155195A5 (OSRAM) | ||
| JP2009504763A5 (OSRAM) | ||
| JP2008501637A5 (OSRAM) | ||
| JP2008512490A5 (OSRAM) |